Memorial Sloan Kettering Cancer Center: Squamous Cell Carcinoma of Head and Neck trials

The registry lists 15 Squamous Cell Carcinoma of Head and Neck studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 6 are open to participants now and 2 have results posted.

Phase 1 5Phase 2 7Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)RecruitingNCT07063212Phase 2
• A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell CarcinomaRecruitingNCT06485778Phase 2
• A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer TreatmentRecruitingNCT05889091Not applicable
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerRecruitingNCT05859074Phase 1
• A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck CancerRecruitingNCT05544136Phase 2
• A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck CancerRecruitingNCT04722523Phase 1
• Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT02684253Phase 2Results posted
• Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RTCompletedNCT01931150Phase 3Results posted
• Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell CarcinomaCompletedNCT03524326Phase 1
• Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal CarcinomaActive, not recruitingNCT03323463Phase 2
• A Dye for the Detection of Cancer of the Tongue and MouthActive, not recruitingNCT03085147Phase 1/2
• Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell CarcinomaCompletedNCT00968435Phase 2
• Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00736619Phase 1
• Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell CarcinomaCompletedNCT00620139
• Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell CarcinomaCompletedNCT00596219Not applicable